Skip to main content

Atlassian Corp

For the period ended Mar 31, 2025. Filed May 2, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 2, 2025

TEAM$148.60-4.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Three Months Ended March 31,Nine Months Ended March 31,
2025202420252024
Cash flows from operating activities:
Net income (loss)$(70,807)$12,752$(232,784)$(103,600)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization23,17823,46469,15455,560
Stock-based compensation346,842282,5191,011,718807,945
Deferred income taxes1,7463,207(1,183)(98)
Amortization of interest rate swap contracts(6,337)—(20,357)—
Net loss on strategic investments6,6434,06024,54611,750
Net foreign currency loss (gain)(5,169)(2,276)(7,750)142
Other(264)412(241)(680)
Changes in operating assets and liabilities, net of business combinations:
Accounts receivable, net53,770(119,819)(13,955)(166,494)
Prepaid expenses and other assets(294)(35,986)(65,967)(59,528)
Accounts payable(93)28,22714,62628,850
Accrued expenses and other liabilities131,50867,14953,80454,958
Deferred revenue171,958301,681253,467393,135
Net cash provided by operating activities652,681565,3901,085,0781,021,940
Cash flows from investing activities:
Business combinations, net of cash acquired(994)—(5,969)(844,727)
Purchases of property and equipment(14,366)(10,520)(29,853)(19,522)
Purchases of strategic investments(1,100)(4,250)(26,650)(8,250)
Purchases of marketable securities(116,716)(74,544)(277,039)(213,690)
Proceeds from maturities of marketable securities53,58463,000125,21279,150
Proceeds from sales of marketable securities and strategic investments2,622—6,93561,392
Net cash used in investing activities(76,970)(26,314)(207,364)(945,647)
Cash flows from financing activities:
Principal payments of term loan facility—(12,500)—(25,000)
Repurchases of Class A Common Stock(134,305)(35,377)(387,156)(203,029)
Other——(3,143)—
Net cash used in financing activities(134,305)(47,877)(390,299)(228,029)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash1,783(2,769)(3,709)(1,986)
Net increase (decrease) in cash, cash equivalents, and restricted cash443,189488,430483,706(153,722)
Cash, cash equivalents, and restricted cash at beginning of period2,218,6391,461,7632,178,1222,103,915
Cash, cash equivalents, and restricted cash at end of period$2,661,828$1,950,193$2,661,828$1,950,193
Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:
Cash and cash equivalents$2,660,859$1,948,978$2,660,859$1,948,978
Restricted cash included in other non-current assets9691,2159691,215
Total cash, cash equivalents, and restricted cash$2,661,828$1,950,193$2,661,828$1,950,193
Non-cash investing and financing activities:
Purchase of property and equipment included in accrued expenses and other current liabilities5,6451,5105,6451,510
Repurchases of Class A Common Stock included in accrued expenses and other current liabilities7,0005,7507,0005,750
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.